Enzalutamide 40MG tab 120/BT chemotherapy
Ended Awarded
- Contract number
- VA24815F2622
- Awardee
-
Astellas Pharma US, Inc. UEI NKGHPQKJQWC1
- Awarding agency
-
Veterans Integrated Service Network 8
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $76,788
Award facts
- Contract value 100% obligated
- $76,788.00 Current and potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- 361 Calle Juan Calaf, San Juan, 00918, Puerto Rico
Award details come from SAM.gov/FPDS.
About this award
This is a delivery order awarded by the U.S. Department of Veterans Affairs (VA) to Astellas Pharma US, Inc., a foreign-owned, for-profit pharmaceutical manufacturer, under the VA's Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs (FSS-61-IB). The $76,788.00 firm-fixed-price contract is for the supply of the oncology medication enzalutamide (XTANDI) 40mg tablets in 120-count bottles, with a period of performance ending on September 30, 2015. Astellas has previously received other VA contract awards to provide pharmaceuticals and hematology-related products to VA medical facilities, including a $3.5 billion FSS contract and two Blanket Purchase Agreements for XTANDI and XOSPATA oncology drugs. This specific delivery order does not have a small business set-aside designation.
Quick answers
Who was awarded contract VA24815F2622?
VA24815F2622 was awarded to Astellas Pharma US, Inc. by Veterans Integrated Service Network 8 (Veterans Health Administration) on August 3, 2015.
How much is contract VA24815F2622 worth?
The government has obligated $76,788 on VA24815F2622.
Is contract VA24815F2622 an order under another contract?
Yes. VA24815F2622 is a delivery order under V797D30296, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract VA24815F2622 competed?
The extent of competition for VA24815F2622 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award